Publications

  1. Tesfaye S, Tandan R, Bastyr EJ III, Kles KA, Skljarevski V, Price KL for the Roboxistaurin Study Group. Factors that impact symptomatic diabetic peripheral neuropathy in placebo-treated patients from two 1-year clinical trials. Diabetes Care. In press.
  2. Brannagan TH, Promisloff RA, McCluskey LF, Mitz KA. Proximal diabetic neuropathy presenting with respiratory weakness. J Neurol Neurosurg Psych 1999;67:539-541.
  3. Alaedini A, Brannagan TH, Sander HW, Chin RL, Latov N. Ganglioside GM3 Antibodies in Diabetic Neuropathy. Neurology. 2004
  4. Chin, RL, Rubin M. Diabetic Neuropathy. In: Poretsky L, ed. Principles of Diabetes Mellitus. Boston: Kluwer Academic Publishers 2002:367-384.
  5. Rosoklija G, Dwork AJ, Younger DS, Karlikaya G, Latov N, Hays AP. Local activation of the complement system in endoneurial microvessels of diabetic neuropathy. Acta Neuropathol 99:55-62, 2000.
  6. Younger DS, Rosoklija G, Hays AP, Trojaborg W, Latov N. Diabetic peripheral neuropathy: a clinicopathological and immunohistochemical analysis of nerve biopsies. Muscle and Nerve 19, 722-727, 1996.
  7. Chokroverty S, Sander HW. AAEM case report #13: diabetic amyotrophy. Muscle Nerve 1996;19:939-945.
  8. Sander HW, Chokroverty S. Diabetic amyotrophy: current concepts. Semin Neurol 1996;16:173-178.
  9. Brannagan TH, Weimer LH, Latov N. Acquired Neuropathies. In Rowland LP, editor. Merritt's Neurology. Lippincott Williams & Wilkins, 11th Edition . Lippincott, Williams and Wilkins. Philadelphia, 2005, chapter 106, pp 746-765.
  10. Brannagan TH. Peripheral Neuropathy Pain: Mechanisms and Treatment. J Clin Neuromuscular Disease. 2003;5:61-71.
Resources
 Alumni e-mail forwarding

 Class broadcast e-mail
Back to Top